Progression of alloresponse and tissue-specific immunity during graft coronary artery disease
- PMID: 15888032
- DOI: 10.1111/j.1600-6143.2005.00880.x
Progression of alloresponse and tissue-specific immunity during graft coronary artery disease
Abstract
Chronic rejection remains the major obstacle for long-term transplant survival. Both indirect alloresponse and tissue-specific autoimmunity have been implicated in its pathogenesis. The interrelationship between these two types of host anti-graft response remains poorly understood. We have developed an immunosuppression-free mouse model of graft coronary artery disease (GCAD), in which all FVB (H-2(q)) cardiac allografts placed into minor Ag (mHC)-mismatched DBA/1 (H-2(q)) hosts survived more than 112 days, and developed GCAD. We then examined the kinetics of both anti-mHC alloresponse and host autoimmunity against heart-specific antigen, cardiac myosin (CM). At 8 days post-transplantation, recipient mice showed minimal intragraft inflammation and apoptosis, and limited expansion of allo-specific T cells. In addition, we observed early production of anti-myosin IgG1 autoantibodies, which occurred in the absence of activated CM-specific T lymphocytes. By day 56, GCAD indices, the numbers of mHC- and CM-reactive T cells, and the levels of circulating allo- and CM-specific antibodies were all significantly increased. While host alloresponse was exhausted at 112 days post-transplant, T-cell reactivity against CM persisted. Our data suggest that both allo- and tissue-specific immunity might contribute to the induction of GCAD. They indicate that continual autoimmune response against graft tissue antigens may provide for GCAD sustenance.
Similar articles
-
T-cell response to cardiac myosin persists in the absence of an alloimmune response in recipients with chronic cardiac allograft rejection.Transplantation. 2002 Oct 15;74(7):1053-7. doi: 10.1097/00007890-200210150-00028. Transplantation. 2002. PMID: 12394855
-
Modulation of tissue-specific immune response to cardiac myosin can prolong survival of allogeneic heart transplants.J Immunol. 2002 Aug 1;169(3):1168-74. doi: 10.4049/jimmunol.169.3.1168. J Immunol. 2002. PMID: 12133936
-
Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.J Immunol. 2000 Sep 15;165(6):3506-18. doi: 10.4049/jimmunol.165.6.3506. J Immunol. 2000. PMID: 10975872
-
Induction of autoimmunity after allotransplantation.Front Biosci. 2007 May 1;12:4362-9. doi: 10.2741/2393. Front Biosci. 2007. PMID: 17485380 Review.
-
Direct and indirect antigen recognition: the pathways to allograft immune rejection.Front Biosci. 1999 May 15;4:D476-80. doi: 10.2741/benichou. Front Biosci. 1999. PMID: 10331992 Review.
Cited by
-
Non-MHC antigenic targets of the humoral immune response in transplantation.Curr Opin Immunol. 2010 Oct;22(5):682-8. doi: 10.1016/j.coi.2010.08.009. Epub 2010 Sep 15. Curr Opin Immunol. 2010. PMID: 20833523 Free PMC article. Review.
-
Autoantibodies to vimentin cause accelerated rejection of cardiac allografts.Am J Pathol. 2007 Apr;170(4):1415-27. doi: 10.2353/ajpath.2007.060728. Am J Pathol. 2007. PMID: 17392180 Free PMC article.
-
Immune responses to self-antigens (autoimmunity) in allograft rejection.Clin Transpl. 2012:261-72. Clin Transpl. 2012. PMID: 23721031 Free PMC article.
-
The importance of non-HLA antibodies in transplantation.Nat Rev Nephrol. 2016 Aug;12(8):484-95. doi: 10.1038/nrneph.2016.88. Epub 2016 Jun 27. Nat Rev Nephrol. 2016. PMID: 27345243 Free PMC article. Review.
-
Antibodies to MHC class I induce autoimmunity: role in the pathogenesis of chronic rejection.J Immunol. 2009 Jan 1;182(1):309-18. doi: 10.4049/jimmunol.182.1.309. J Immunol. 2009. PMID: 19109162 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials